Partnering with Ipsen | Collaborative Healthcare Innovation

Partnering

We believe great partnerships create great possibilities and are inspired by our partners

As a global biopharmaceutical company, we leverage our agility, R&D capabilities and global footprint to develop valuable business partnerships that fuel tomorrow’s breakthrough discoveries across our three therapeutic areas: Oncology, Rare Disease and Neuroscience. External innovation is at the heart of our strategy. We believe in the expertise of our partners and value the opportunity to collaborate, bringing our skills, experience and global reach to accelerate innovation to bring new medicines to patients.

Exclusively sourcing our pipeline through external innovation, we have no internal competing pipeline as we recognize the best science is delivered in biotech and academic institutions.  We are proud our team comprises talents attracted from Pharma, biotech and academia, to drive shared success through creative collaborations.

We have the tenacity

to carry your innovations  forward

 

Desktop Image

Ipsen Key Facts

Contact the partnering team

At Ipsen, entering partnerships is always personal. Our team is committed to success and has the expertise to deliver it. Contact us to see how together, we can accelerate innovation for patients.

Partnering events

Throughout the year, Ipsen holds numerous events for and with partners. Look through our upcoming events if you are interested in our work and in partnering with us and would like to meet our team.

Top stories in partnering

22 July 2024 0 mins read

Financial results for the first half of 2024

The financial results for the first half of the year will be published on July 25, 2024 at 7H00 and a conference call will take place at 13H00 CET.

31 May 2024 1 mins read

Our 2023 Integrated Annual Report is live!

In 2023, we entered the next phase of our journey of growth and innovation, reinforcing our position as a leading mid-sized biopharmaceutical company. With a sharp focus on our three therapy areas of Oncology, Rare Diseases, and Neuroscience, we achieved total sales of €3,128 m.

22 April 2024 3 mins read

Navigating Proactive Sustainability in Pharma R&D and Partnering

In March, we were proud to see Florence Dal Degan, Senior Director of External Innovation, participate in a panel discussion with different stakeholders, from consulting firms, pharma companies, investors to startups at BioEurope Spring entitled “Towards a Greener Globe: Biopharma’s Path to Sustaina

19 April 2024 0 mins read

Q1 2024 sales update

The Q1 2024 sales announcement will be published on April 24, 2024 at 7am CET. Find out more and register for the conference call for investors and analysts.

02 April 2024 3 mins read

Unlocking Potential Through Early-Stage Partnerships

We are pleased to share a recent conversation with Mary Jane Hinrichs, Senior Vice President, and Global Head of Early Development. Mary Jane spearheads the strategic direction and execution of early-stage programs at Ipsen, guiding them from drug candidate to…

15 March 2024 2 mins read

Applications now open for the 2024 Golden Ticket competition

As part of our commitment to accelerating transformative research and development, we’re excited to announce that our annual Golden Ticket competition is now open! Through our continued partnership with BioLabs, we’re delighted to be offering the brightest minds in biotech…

14 March 2024 2 mins read

Focus; Confidence; Commitment – The Building Blocks of Win-Win Partnerships 

Ipsen’s Senior Director of Global Partnering for Oncology, Madee Gooriah, is part of the team leading efforts to expand Ipsen’s oncology franchise through external partnerships at every stage of development. But in an industry marked by complexity, how do we…

08 February 2024 0 mins read

FY 2023 results announcement 

Ipsen’s FY 2023 results announcement took place on 8 February 2024 at 7am CET/1am EST.

21 December 2023 2 mins read

J.P. Morgan 2024: Ipsen discusses progress, next phase of growth and partnering ambition

At the J.P. Morgan Healthcare Conference in San Francisco from January 8 to 11, 2024,  Ipsen’s management team leaders will discuss our transformation story, next phase of growth and external innovation ambitions.

20 November 2023 1 mins read

Ipsen sponsors 5 elite athletes on their journeys to the 2024 Paralympics

Starting now and throughout 2024, Ipsen is sponsoring five talented, elite athletes on their journeys toward the 2024 Paralympic Games.